Success Metrics

Clinical Success Rate
60.0%

Based on 6 completed trials

Completion Rate
60%(6/10)
Active Trials
2(14%)
Results Posted
33%(2 trials)
Terminated
4(29%)

Phase Distribution

Ph phase_1
4
29%
Ph phase_4
4
29%
Ph phase_2
2
14%
Ph not_applicable
4
29%

Phase Distribution

4

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
4(28.6%)
Phase 2Efficacy & side effects
2(14.3%)
Phase 4Post-market surveillance
4(28.6%)
N/ANon-phased studies
4(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(6)
Terminated(4)
Other(2)

Detailed Status

Completed6
Terminated4
Recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (28.6%)
Phase 22 (14.3%)
Phase 44 (28.6%)
N/A4 (28.6%)

Trials by Status

recruiting214%
terminated429%
completed643%
unknown214%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14